Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Conler Pharm Logo
Conler Pharm Growth Score
68
CB Rank
235543
Heat Score
50
Conler Pharm is the producer of API and finished drug development services.
Founded
obfuscation
PublicPost-IPO Equity Wenzhou, Zhejiang, China11-50 www.conlerpharm.com/en
Health Care
Medical
Pharmaceutical
Overview

Conler Pharm
Total Funding
obfuscation
Growth Score
68
Heat Score
50

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score68
-5 pts
in past quarter
Heat Score 50
-20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Conler Pharm

CB Rank
235543
Conler Pharm is the producer of API and finished drug development services.
Founded
obfuscation
PublicPost-IPO Equity Wenzhou, Zhejiang, China11-50 www.conlerpharm.com/en
Health Care
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Details

Legal Name Zhejiang Kangle Pharmaceutical Co., Ltd.
Also Known As 康乐药业, 浙江康乐药业股份有限公司
Operating Status Active
Stock Symbol  NEEQ:832126
Company Type For Profit
About the Company

Conler Pharm is a manufacturer of paracetamol and paracetamol DC. The company provides products like products are famotidine tablets, acetaminophen tablets, compound paracetamol tablets, polygeline injection, erdosteine capsules, compound paracetamol and chlorphenamine maleate granules, pediatric paracetamol, artificial cow-bezoar and

chlorphenamine maleate granules and etc. The company also provides medical equipment.

Phone Number +86-577-88593558
Contact Email sales@conlerpharm.com
Predictions & Insights

Products & Services

API Production
Manufacture of active pharmaceutical ingredients (APIs) used in drug formulation and development.
Finished Drug Development Services
Services related to the development and production of finished pharmaceutical products ready for market use.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Conler Pharm Logo
Post-IPO Equity - Conler Pharm
1
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

Monthly Web Visits

46
-34.29%
 in past month

Active Website Tech Count

4Conler Pharm is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Pound Sterling, and  Japanese Yen.

Total IP

2Conler Pharm has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Conler Pharm's headquarters? Conler Pharm is located in Wenzhou, Zhejiang, China.Who invested in Conler Pharm? Conler Pharm is funded by Zhejiang Cheng Yi Pharmaceutical.When was the last funding round for Conler Pharm? Conler Pharm closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Conler Pharm raised to date? Conler Pharm has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|